BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22377627)

  • 1. Administration of poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) as adjuvant activated mixed Th1/Th2 immune responses in pigs.
    Dar A; Lai K; Dent D; Potter A; Gerdts V; Babiuk LA; Mutwiri GK
    Vet Immunol Immunopathol; 2012 May; 146(3-4):289-95. PubMed ID: 22377627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G; Benjamin P; Soita H; Babiuk LA
    Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens.
    Mutwiri G; Benjamin P; Soita H; Townsend H; Yost R; Roberts B; Andrianov AK; Babiuk LA
    Vaccine; 2007 Jan; 25(7):1204-13. PubMed ID: 17140708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of immunogenicity and protective efficacy of Actinobacillus pleuropneumoniae HB04C(-) mutant lacking a drug resistance marker in the pigs.
    Bei W; He Q; Zhou R; Yan L; Huang H; Chen H
    Vet Microbiol; 2007 Nov; 125(1-2):120-7. PubMed ID: 17580102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immune response profiles in pigs injected with vaccine adjuvants polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) and Emulsigen.
    Magiri R; Lai K; Huang Y; Mutwiri G; Wilson HL
    Vet Immunol Immunopathol; 2019 Mar; 209():7-16. PubMed ID: 30885308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
    Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
    Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.
    Shin MK; Kang ML; Jung MH; Cha SB; Lee WJ; Kim JM; Kim DH; Yoo HS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):132-9. PubMed ID: 23206402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccine encoding type IV pilin of Actinobacillus pleuropneumoniae induces strong immune response but confers limited protective efficacy against serotype 2 challenge.
    Lu YC; Li MC; Chen YM; Chu CY; Lin SF; Yang WJ
    Vaccine; 2011 Oct; 29(44):7740-6. PubMed ID: 21835218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae.
    Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S
    Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different doses of antigen for intradermal administration in pigs: the Actinobacillus pleuropneumoniae model.
    Bernardy J; Nechvatalova K; Krejci J; Kudlacková H; Brazdova I; Kucerova Z; Faldyna M
    Vaccine; 2008 Nov; 26(50):6368-72. PubMed ID: 18824203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AasP autotransporter protein of Actinobacillus pleuropneumoniae does not protect pigs against homologous challenge.
    Oldfield NJ; Worrall KE; Rycroft AN; Ali T; Wooldridge KG; Ala'Aldeen DA
    Vaccine; 2009 Aug; 27(38):5278-83. PubMed ID: 19563888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of immune response genes to adjuvants poly [di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP), CpG oligodeoxynucleotide and emulsigen at intradermal injection site in pigs.
    Magiri RB; Lai K; Chaffey AM; Wilson HL; Berry WE; Szafron ML; Mutwiri GK
    Vet Immunol Immunopathol; 2016 Jul; 175():57-63. PubMed ID: 27269793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue reaction and immunity in swine immunized with Actinobacillus pleuropneumoniae vaccines.
    Willson PJ; Rossi-Campos A; Potter AA
    Can J Vet Res; 1995 Oct; 59(4):299-305. PubMed ID: 8548692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model.
    Chiang CH; Huang WF; Huang LP; Lin SF; Yang WJ
    Vaccine; 2009 Jul; 27(34):4565-70. PubMed ID: 19520199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant ApxIV protein enhances protective efficacy against Actinobacillus pleuropneumoniae in mice and pigs.
    Wu HC; Yeh PH; Hsueh KJ; Yang WJ; Chu CY
    J Appl Microbiol; 2018 Jun; 124(6):1366-1376. PubMed ID: 29431246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses to in ovo vaccine formulations containing inactivated fowl adenovirus 8b with poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) and avian beta defensin as adjuvants in chickens.
    Sarfraz M; Suleman M; Tikoo SK; Wheler C; Potter AA; Gerdts V; Dar A
    Vaccine; 2017 Feb; 35(6):981-986. PubMed ID: 28087147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of pigs from swine dysentery by vaccination with recombinant BmpB, a 29.7 kDa outer-membrane lipoprotein of Brachyspira hyodysenteriae.
    La T; Phillips ND; Reichel MP; Hampson DJ
    Vet Microbiol; 2004 Aug; 102(1-2):97-109. PubMed ID: 15288932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of adjuvant to adaptive immune responses in mice against Actinobacillus pleuropneumoniae.
    San Gil F; Turner B; Walker MJ; Djordjevic SP; Chin JC
    Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2595-2603. PubMed ID: 10517613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide screening of lipoproteins in Actinobacillus pleuropneumoniae identifies three antigens that confer protection against virulent challenge.
    Cao Y; Gao L; Zhang L; Zhou L; Yang J; Deng L; Zhao J; Qi C; Liu J
    Sci Rep; 2020 Feb; 10(1):2343. PubMed ID: 32047221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) and Avian Beta Defensin as Adjuvants in Inactivated Inclusion Body Hepatitis Virus and its Hexon Protein-Based Experimental Vaccine Formulations in Chickens.
    Dar A; Tipu M; Townsend H; Potter A; Gerdts V; Tikoo S
    Avian Dis; 2015 Dec; 59(4):518-24. PubMed ID: 26629626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.